# An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer (VIRGO)

> **NCT00726661** · — · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 1287 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00726661
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 1287 (ACTUAL)
- **Last updated:** 2017-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00726661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00726661, "An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer (VIRGO)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00726661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*